Spain: Anaconda Biomed raises €20m in Series B funding

Anaconda Biomed management team

Anaconda Biomed, a medical technology company developing thrombectomy systems for the treatment of ischemic stroke, has closed €20m (US$22m) in Series B funding. The funding will be used for clinical studies of the company’s groundbreaking technology, regulatory submissions in international markets, further product development and manufacturing scale-up. “With this new round of funding, we will…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »